Clinical Trial Update: Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ivonescimab in combination with paclitaxel and cisplatin as neoadjuvant therapy followed by type A hysterectomy for stage IB2 to IIA1 c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Ivonescimab (AK112/SMT112)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Obstetrics & Gynecology Hospital of Fudan University | Conditions: Cervical Cancers | Phase 2 | Status: RECRUITING